Carl Dambkowski - Jul 13, 2023 Form 3/A - Amendment Insider Report for Apogee Therapeutics, Inc. (APGE)

Signature
/s/ Jane Pritchett Henderson, as attorney-in-fact for Carl Dambkowski
Stock symbol
APGE
Transactions as of
Jul 13, 2023
Transactions value $
$0
Form type
3/A - Amendment
Date filed
7/17/2023, 05:06 PM
Date Of Original Report
Jul 13, 2023
Next filing
Dec 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding APGE Common Stock 301K Jul 13, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of (i) 131,992 shares of restricted common stock, one quarter of which will vest on September 16, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, and (ii) 168,796 shares of restricted common stock, one quarter of which will vest on December 14, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, in each case subject to the Reporting Person's continued service to the Issuer.
F2 This amendment is being filed to correct the number of shares reported in Table I due to a calculation error.